Yang Y - Search Results

1

C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome.

Tsao AS, Kantarjian H, Thomas D, Giles F, Cortes J, Garcia-Manero G, Huh Y, Yang Y, Shen Y, Albitar M, Estey E. Tsao AS, et al. Among authors: yang y. Leuk Res. 2004 Apr;28(4):373-8. doi: 10.1016/j.leukres.2003.09.008. Leuk Res. 2004. PMID: 15109537

2

Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.

Amin HM, Yang Y, Shen Y, Estey EH, Giles FJ, Pierce SA, Kantarjian HM, O'Brien SM, Jilani I, Albitar M. Amin HM, et al. Among authors: yang y. Leukemia. 2005 Sep;19(9):1567-72. doi: 10.1038/sj.leu.2403876. Leukemia. 2005. PMID: 16049515

3

Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate.

Kantarjian HM, O'Brien S, Cortes JE, Smith TL, Rios MB, Shan J, Yang Y, Giles FJ, Thomas DA, Faderl S, Garcia-Manero G, Jeha S, Wierda W, Issa JP, Kornblau SM, Keating M, Resta D, Capdeville R, Talpaz M. Kantarjian HM, et al. Among authors: yang y. Clin Cancer Res. 2002 Jul;8(7):2167-76. Clin Cancer Res. 2002. PMID: 12114417 Clinical Trial.

4

Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.

Hu Q, Dey AL, Yang Y, Shen Y, Jilani IB, Estey EH, Kantarjian HM, Giles FJ, Albitar M. Hu Q, et al. Among authors: yang y. Cancer. 2004 May 1;100(9):1884-91. doi: 10.1002/cncr.20187. Cancer. 2004. PMID: 15112269 Free article.

5

The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome.

Hock BD, McKenzie JL, Patton WN, Haring LF, Yang Y, Shen Y, Estey EH, Albitar M. Hock BD, et al. Among authors: yang y. Cancer. 2003 Oct 15;98(8):1681-8. doi: 10.1002/cncr.11693. Cancer. 2003. PMID: 14534885 Free article.

6

The human MDM-2 oncogene is overexpressed in leukemias.

Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M. Bueso-Ramos CE, et al. Among authors: yang y. Blood. 1993 Nov 1;82(9):2617-23. Blood. 1993. PMID: 8219216 Free article.

7

Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia.

Thomas MB, Koller C, Yang Y, Shen Y, O'Brien S, Kantarjian H, Davis J, Estey E. Thomas MB, et al. Among authors: yang y. Leukemia. 2003 May;17(5):990-3. doi: 10.1038/sj.leu.2402862. Leukemia. 2003. PMID: 12750721 No abstract available.

8

Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.

Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Shen Y, et al. Among authors: yang y. J Natl Cancer Inst. 2005 Aug 17;97(16):1195-203. doi: 10.1093/jnci/dji239. J Natl Cancer Inst. 2005. PMID: 16106024

9

Abnormal expression of MDM-2 in breast carcinomas.

Bueso-Ramos CE, Manshouri T, Haidar MA, Yang Y, McCown P, Ordonez N, Glassman A, Sneige N, Albitar M. Bueso-Ramos CE, et al. Among authors: yang y. Breast Cancer Res Treat. 1996;37(2):179-88. doi: 10.1007/BF01806499. Breast Cancer Res Treat. 1996. PMID: 8750585

10

Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.

Slaton JW, Millikan R, Inoue K, Karashima T, Czerniak B, Shen Y, Yang Y, Benedict WF, Dinney CP. Slaton JW, et al. Among authors: yang y. J Urol. 2004 Feb;171(2 Pt 1):570-4. doi: 10.1097/01.ju.0000108845.91485.20. J Urol. 2004. PMID: 14713761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107,759 results

Search Page

Filters